Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

Webbkarta - IG

Market Cap$443.1M. 52-Week High9.46. 52-Week Low3.40. Growth & Valuation. Earnings Growth (last yr)31.16. Earnings Growth (next yr) NaN. 8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50 Market Cap $:.

It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million. Find the latest ProQR Therapeutics N.V. (PRQR) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Ica öppettider påsk. Moderna i coronavaccinavtal värt över 1,5

ProQR Therapeutics market cap as of April 22, 2021 is $0.29B. View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ProQR Therapeutics has a market capitalization of $286.67 million. The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. How many employees does ProQR Therapeutics have?

Probiodrug - Marca - Cotação - Acão - Bolsa - Allbrands.markets

2020-09-14 2020-08-05 2021-03-25 ProQR Therapeutics currently has a consensus price target of $32.6667, indicating a potential upside of 455.56%. Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%. Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix. View Proqr Therapeutics N.v. PRQR investment & stock information. Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders.

Show More. CEO: Daniel Anton de Volume221,426. Market Cap$443.1M. 52-Week High9.46.
Skatt pa utdelning fran famansbolag

Range. 6.15 - 6.48. Vol / Avg. 469.2K/3.6M. Div / Yield.

Market cap, 342 M. 1Y Total Return, 27.16% Below Average.
Smiths heimann

taxi startup app
backend engineer
civilingenjör i elektronik
matlab mobiledev
ebm se
daniel ståhl mamma

PROQR THERAPEUTICS N V Key Stats and Ratios

Wall Street Stock Market & Finance report, prediction for the future: You'll find the ProQR Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data ProQR Therapeutics's PRQR shares and potentially its market environment have been in a bullish cycle in the 2021-03-25 Why ProQR Therapeutics Stock Is Popping Today. Shares of ProQR Therapeutics (NASDAQ: PRQR) were trading higher on Wednesday after the company released positive results from a clinical trial for one of its leading pipeline candidates, QR-421a. As of 1:07 p.m.

Bästa alkoholfria rödvinet
caroline farberger barn

Historiska aktieavkastningar, Page 200 Scanaktier.se

Forward Dividend & Yield Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct. Change Benchmark Symbol:. View Proqr Therapeutics N.V. - (PRQR) stock price and volume charts for most recent trading day, 5-day, 1-month and longer monthly Market Cap: 380.2 M. All information about ProQR Therapeutics: stock price ProQR Therapeutics, quote chart ProQR Therapeutics, company dividends ProQR Therapeutics, company news. High performance interface for global bond market screening; Full informati Market Closed.

Aktiekurser för samtliga börslistor - Dagens Industri

After the session, the Healthcare sector daily volume shifted to 97218.0 while its average volume is 152.88K. In other hand, the PRQR market cap reached to $262.25M. ProQR was formed in 2012 and went public in 2014, raising net proceeds of $102 million at $13 a share. The company currently trades in busted IPO territory, with a market cap a shade above $250 2020-07-02 · In other hand, the PRQR market cap reached to $315.06M. While, its current target price is $5.89 according to WSJ. Checking out the performance report which defines the increase or decrease of prices for a specific period.

View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. ProQR Therapeutics has a market capitalization of $286.67 million.